The Effect of Educational Intervention on The Patient’S Willingness to Carry Out The Immunochemical Faecal Occult Blood Test for Colorectal Cancer / Vpliv Izobraževalnega Ukrepa Na Pacientovo Pripravljenost Za Izvedbo Imunokemičnega Testa Za Določanje Okultne Krvi V Blatu Za Raka Debelega Črevesa In Danke

1. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of CRC. N Engl J Med 2000; 343: 1603-7.10.1056/NEJM20001130343220311096167Search in Google Scholar

2. Cancer screening in the European Union: report on the implementation of the Council. Available Jan 14, 2014 from: http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_screening.pdfSearch in Google Scholar

3. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010; 105: 682-90.10.1038/ajg.2009.66819953091Search in Google Scholar

4. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, et al. A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med 2005; 142: 86-94.10.7326/0003-4819-142-2-200501180-0000715657156Search in Google Scholar

5. Steele RJC, Kostourou I, Clements PM, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010; 17: 68-74.10.1258/jms.2010.00912020660434Search in Google Scholar

6. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for CRC: patient response and detection rates. J Natl Cancer Inst 2005; 97: 347-57.10.1093/jnci/dji05015741571Search in Google Scholar

7. Shastri YM, Loitsch S, Hoepffner N, Povse N, Hanisch E, Rösch W, et al. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study. Am J Gastroenterol 2008; 103: 1496-1504.10.1111/j.1572-0241.2008.01824.x18510609Search in Google Scholar

8. The American Cancer Society. Global cancer facts & figures. 2nd ed. Atlanta: American Cancer Society, 2011.Search in Google Scholar

9. The guide to medicare preventive services for physicians, suppliers and other health care professionals, CMS, Dept. of Health and Human Services- USA, 2005. Available Jan 13, 2014 from: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/psguid.pdf.Search in Google Scholar

10. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood test to increased CRC screening. J Natl Cancer Inst 2004; 96: 770-80.10.1093/jnci/djh13415150305Search in Google Scholar

11. Seifert B, Zavoral M, Fric P, Bencko V. The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma 2008; 55: 74-80.Search in Google Scholar

12. Berchi C, Dupuis JM, Launoy G. The reasons of general practitioners for promoting CRC mass screening in France. Eur J Health Econ 2006; 7: 91-8.10.1007/s10198-006-0339-016474967Search in Google Scholar

13. Brawarsky P, Brooks DR. Effect of physician recommendation and patient adherence on rates of CRC testing. Cancer Detect Prev 2004; 28: 260-8.10.1016/j.cdp.2004.04.00615350629Search in Google Scholar

14. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Available Jan 10, 2014 from: http:// www.kolorektum.cz/res/file/guidelines/CRC-screening-guidelines-EC-2011-02-03.pdfSearch in Google Scholar

15. Faivre J, Dancourt V, Lejeune C. Screening for colorectal cancer with immunochemical faecal occult blood tests. Dig Liver Dis 2012; 44: 967-73.10.1016/j.dld.2012.07.00422898146Search in Google Scholar

16. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med 2003; 36: 525-35.10.1016/S0091-7435(03)00016-1Search in Google Scholar

17. National Centre on Health Information and Analysis. Mortality by main causes in the Republic of Bulgaria, 2011. Available Jan 10, 2014 from: http://ncphp.government.bg/files/nczi/izdania_2010/buletin_Death_11.pdf , last accessSearch in Google Scholar

18. Damyanov D, Kurtev P. Present state and perspectives in CRC treatment. Scr Sci Med 2007; 39(Suppl): 217-21.Search in Google Scholar

19. Jatoi I, Anderson WF. Cancer screening. Curr Probl Surg 2005; 42: 620-82.10.1067/j.cpsurg.2005.06.00316154400Search in Google Scholar

20. van Dam L, Hol L, de Bekker-Grob EW, Steyerberg EW, Kuipers EJ, Habbema JD, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2010; 46: 150-9.10.1016/j.ejca.2009.07.01419683432Search in Google Scholar

21. Dimova R, R. Stoyanova, B. Levterova, R. Dimov. ‘Doctor-patient compliance’ in introducing of fecal immunochemical occult blood test - cross - sectional survey in Bulgaria. Euras J Fam Med 2012; 2: 55-62.Search in Google Scholar

22. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and CRCs: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 2012; 43: 97-118.10.1016/j.amepre.2012.04.00922704754Search in Google Scholar

23. Chachevski N. Screening in the general medical practice: PhD thesis. Plovdiv: Faculty of Public Health, Medical University, 2009.Search in Google Scholar

24. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005; 41: 23-9.10.1016/j.ypmed.2004.11.00415916989Search in Google Scholar

25. Dimova R, Dimov R. Attitudes, motivation and behavior of general practitioners toward performance of colorectal carcinoma screening programme. General Medicine 2007; 9: 6-11.Search in Google Scholar

26. Dimitrova D. Factors limiting the participation of patients in screening programs. In: Scientific conference 4-5. 11. 2009: proceedings. Plovdiv: Union of Scientists in Bulgaria, Scientific Researchers of the Union of Scientists in Bulgaria, 2010: 108-12.Search in Google Scholar

27. Census 2011 in Bulgaria. Available Jan 6, 2014 from: 28. http://www.nsi.bg/census2011/PDOCS2/Census2011final_en.pdf Search in Google Scholar